CASSIOPEIA: A phase 2 study evaluating efficacy and safety of tisagenlecleucel in first-line therapy for high-risk pediatric and young adult patients with B-cell Acute Lymphoblastic Leukemia (B-ALL) who are MRD positive at the End of Consolidation (EOC)

J. Buechner, S. Rives, S. Maude,S. Hunger,S. Grupp, J. Levine,T. Feuchtinger, A. Zia, J. Davis, L. Pacaud, U. Deore,M. Loh

ONCOLOGY RESEARCH AND TREATMENT(2020)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要